| Jeffrey Guller, MD | |
|
9149 Estate Thomas, Paragon Medical Bldg, Ste 103, St Thomas, VI 00802-2615 | |
| (340) 774-0265 | |
| (340) 776-0228 |
| Full Name | Jeffrey Guller |
|---|---|
| Gender | Male |
| Speciality | Radiology - Vascular & Interventional Radiology |
| Location | 9149 Estate Thomas, St Thomas, Virgin Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356341705 | NPI | - | NPPES |
| 01086566 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0204X | Radiology - Vascular & Interventional Radiology | 1330 (Virgin Island) | Primary |
| Entity Name | St Thomas Radiology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659385011 PECOS PAC ID: 0042235137 Enrollment ID: O20051007000487 |
News Archive
Health and Human Services Secretary Kathleen Sebelius today released new data from the Nationwide Emergency Department Sample - the largest, all-payer emergency department database in the United States.
After more than a decade of steady improvements, the decline in mortality rates from heart disease and stroke has slowed nationally and nearly leveled out since 2011, according to a new analysis from Kaiser Permanente published in JAMA Cardiology.
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will be presenting detailed results from its recently completed Phase 2a FDA trial on ORMD-0801, its orally ingestible insulin capsule at the 2014 GTC Diabetes Summit taking place from April 23-25, 2014, in Boston, Massachusetts, USA.
University of Granada and the Spanish Consejo Superior de Investigaciones Cient-ficas (CSIC) researchers will use nanoscopic clay for the controlled release of drugs in patients, with the aim of designing more efficient and less toxic drugs. This is a pilot research study that includes CSIC and University of Granada researchers and researchers from other institutions.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Guller, MD Po Box 11839, St Thomas, VI 00801-4839 Ph: (340) 774-0265 | Jeffrey Guller, MD 9149 Estate Thomas, Paragon Medical Bldg, Ste 103, St Thomas, VI 00802-2615 Ph: (340) 774-0265 |
News Archive
Health and Human Services Secretary Kathleen Sebelius today released new data from the Nationwide Emergency Department Sample - the largest, all-payer emergency department database in the United States.
After more than a decade of steady improvements, the decline in mortality rates from heart disease and stroke has slowed nationally and nearly leveled out since 2011, according to a new analysis from Kaiser Permanente published in JAMA Cardiology.
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will be presenting detailed results from its recently completed Phase 2a FDA trial on ORMD-0801, its orally ingestible insulin capsule at the 2014 GTC Diabetes Summit taking place from April 23-25, 2014, in Boston, Massachusetts, USA.
University of Granada and the Spanish Consejo Superior de Investigaciones Cient-ficas (CSIC) researchers will use nanoscopic clay for the controlled release of drugs in patients, with the aim of designing more efficient and less toxic drugs. This is a pilot research study that includes CSIC and University of Granada researchers and researchers from other institutions.
› Verified 3 days ago